Michelle Mitchell: Science, research and innovation has delivered huge achievements

Michelle Mitchell shared a post on LinkedIn:

“Science, research and innovation has delivered huge achievements. Thanks to advances in our understanding of cancer prevention, diagnosis and treatment, cancer survival has doubled in the past 50 years.

In 2024 we’re likely to have a General Election. This presents an opportunity for all political parties to commit to sustainable and long-term funding for research, to transform cancer outcomes and improve the lives of cancer patients now and in the future.”

View additional information.
Source: Michelle Mitchell/LinkedIn

Michelle Mitchell is the first female chief executive of Cancer Research UK (CRUK), the world’s leading charitable funder of cancer research. In 2021/22 the charity had an income of £668m, spent £443m on cancer research and had approximately 4,000 staff and over 30,000 volunteers. Before joining Cancer Research UK, Michelle was CEO of the MS Society for five years and a founding member of the Progressive MS Alliance: a global scientific and research joint venture and launched the STOP MS £100m appeal.

Prior to that, she was Director General at Age UK, the UK’s largest older people’s charity where she worked for nearly a decade and was at the forefront of national debates on health, care and welfare. Mitchell was appointed Order of the British Empire (OBE) in the 2016 New Year Honours for services to Older People and the Voluntary Sector. She was named by Cranfield University as one of the 100 Women to Watch in 2018.